Literature DB >> 17928051

A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts.

Thomas Burmeister1, Richard Reinhardt.   

Abstract

RT-PCR is the method of choice for detecting BCR-ABL in CML and ALL. The three predominant mRNA transcripts found are e1a2 (in ALL), e13a2, and e14a2 (in CML and ALL). However, a number of "atypical"BCR-ABL transcripts (e1a3, e13a3, e14a3, e19a2, e6a2, e8a2, etc.) resulting from chromosomal breakpoints outside ABL intron 1 or BCR intron 1, 13 or 14, respectively, have been reported. These atypical transcripts may escape detection when using methods that are optimized to detect just the typical ones. We present here a novel, fast, and reliable multiplex PCR for improved detection of typical and atypical BCR-ABL transcripts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928051     DOI: 10.1016/j.leukres.2007.08.017

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  14 in total

Review 1.  Molecular monitoring in CML: how deep? How often? How should it influence therapy?

Authors:  Naranie Shanmuganathan; Timothy P Hughes
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Is the BCR-ABL1 transcript type in chronic myeloid leukaemia relevant?

Authors:  Stephen E Langabeer
Journal:  Med Oncol       Date:  2013-02-21       Impact factor: 3.064

3.  Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.

Authors:  Michele Massimino; Stefania Stella; Elena Tirrò; Maria Letizia Consoli; Maria Stella Pennisi; Adriana Puma; Silvia Rita Vitale; Chiara Romano; Valentina Zammit; Fabio Stagno; Francesco Di Raimondo; Livia Manzella
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

4.  Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript.

Authors:  Sang-Yong Shin; Jin-Hee Cho; Hee-Jin Kim; Jun-Ho Jang; Seung-Tae Lee; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

5.  Variant BCR-ABL1 fusion genes in adult Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia.

Authors:  Stephen E Langabeer
Journal:  EXCLI J       Date:  2017-10-18       Impact factor: 4.068

6.  Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia.

Authors:  Z Gong; L J Medeiros; J E Cortes; L Zheng; J D Khoury; W Wang; G Tang; S Loghavi; R Luthra; W Yang; H M Kantarjian; S Hu
Journal:  Blood Cancer J       Date:  2017-07-14       Impact factor: 11.037

7.  Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients.

Authors:  Mahmood S Khazaal; Farqad B Hamdan; Qasim S Al-Mayah
Journal:  Mol Genet Genomic Med       Date:  2019-06-17       Impact factor: 2.183

8.  Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.

Authors:  Justin T Brown; Ion J Beldorth; Walairat Laosinchai-Wolf; Marie E Fahey; Keri L Jefferson; Adam K Ruskin; Jacquelyn J Roth; Li Cai; Christopher D Watt; Richard D Press; Fei Yang; John B Hedges; Bernard F Andruss
Journal:  J Mol Diagn       Date:  2019-04-23       Impact factor: 5.568

9.  Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts.

Authors:  Michele Massimino; Elena Tirrò; Stefania Stella; Livia Manzella; Maria Stella Pennisi; Chiara Romano; Silvia Rita Vitale; Adriana Puma; Cristina Tomarchio; Sandra Di Gregorio; Agostino Antolino; Francesco Di Raimondo; Paolo Vigneri
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810

10.  Characteristics of BCR-ABL gene variants in patients of chronic myeloid leukemia.

Authors:  Huma Amin; Suhaib Ahmed
Journal:  Open Med (Wars)       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.